Skip to content

Long-term efficacy and safety of an ultrasound-guided radiofrequency ablation system for the treatment of lower-extremity varicose veins: a prospective, single-arm, multicenter clinical trial

Long-term efficacy and safety of an ultrasound-guided radiofrequency ablation system for the treatment of lower-extremity varicose veins: a prospective, single-arm, multicenter clinical trial

Status
Active, not recruiting
Phases
Phase 4
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2400084640
Enrollment
Unknown
Registered
2024-05-22
Start date
2024-06-01
Completion date
Unknown
Last updated
2024-07-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Varicose veins of the lower extremities, as a form of chronic venous disease (CVD), is one of the most common diseases of the venous system, with only cosmetic changes in the early stages, but with the aggravation of the varicose veins, there are complications such as swelling of the lower extremities, hyperpigmentation, itching of the skin, difficulty in walking, liposclerosis, and even hemorrhag

Interventions

Venous RF Radiofrequency Ablation System Treatment Group:Ultrasound guided Venous RF radiofrequency ablation system for the treatment of lower limb varicose veins

Sponsors

Zhongshan Hospital, Fudan University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 85 Years

Inclusion criteria

Inclusion criteria: 1. A clear diagnosis of primary lower extremity varicose veins by clinical examination; 2. CEAP grading of C2-C6; 3. Target veins 2 mm = diameter = 15 mm and deep vein patency; 4. Expected survival = 1 year; 5. can tolerate surgery; 6. no serious psychiatric diseases as well as organic diseases; 7. no history of allergy to sclerosing agent and anesthesia.

Exclusion criteria

Exclusion criteria: 1. Patients with combined lower extremity DVT (deep vein thrombosis); 2. patients with acute thrombosis within the main trunk of the saphenous vein; 3. patients with iliac vein compression syndrome; 4. patients with verrucous dilatation of the femoral saphenous junction; 5. patients with a previous history of lower extremity varicose vein surgery; 6. severe tortuosity of the saphenous vein that prevents passage of the radiofrequency catheter; 7. uncorrected coagulopathy; 8. patients with severe hepatic and renal dysfunction; 9. patients on bed rest; 10. patients who are pregnant or breastfeeding, or who are scheduled to give birth during the study; 11. Participating in other device or drug clinical trials; 12. are, in the judgment of the investigator, unsuitable for participation in the clinical trial.

Design outcomes

Primary

MeasureTime frame
Saphenous vein trunk closure rate at 2 years postoperatively;

Secondary

MeasureTime frame
Instant technical success rate;Venous Clinical Severity Score (VCSS) before and after surgery;Aberdeen Varicose Vein Questionnaire (AVVQ) before and after surgery;Complication rate;Performance Evaluation of Venous Ablation Generator and Venous Ablation Catheter;

Countries

China

Contacts

Public ContactWeiguo Fu

Zhongshan Hospital, Fudan University

fu.weiguo@zs-hospital.sh.cn+86 21 64041990

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026